Sino Biological,Inc. (SHE:301047)

China · Delayed Price · Currency is CNY

73.28

-0.56 (-0.76%)

At close: Feb 13, 2026

16.86% (1Y)

Market Cap	8.91B +23.3%
Revenue (ttm)	660.17M +3.9%
Net Income	132.79M -13.9%
EPS	1.08 -10.8%
Shares Out	121.64M
PE Ratio	68.16
Forward PE	63.45
Dividend	4.00 (5.42%)
Ex-Dividend Date	Sep 22, 2025

Volume	554,400
Average Volume	1,177,799
Open	73.88
Previous Close	73.84
Day's Range	73.28 - 74.39
52-Week Range	57.40 - 85.00
Beta	1.04
RSI	46.35
Earnings Date	Apr 14, 2026

About Sino Biological,Inc.

Sino Biological,Inc. provides recombinant protein and antibody reagents for life science researchers in China and internationally. The company offers recombinant proteins, antibodies, cDNA clones, kits, serum-free media, protein modification, qPCR primers, cell lysates, and purification reagents. It also provides comprehensive solutions, including autoimmune disease research, kinase drug discovery, cytokine and growth factor, SARS-CoV-2 variants research, comprehensive CAR-T therapy, 3D organoids research, ADC development, influenza vaccine dev... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2016

Employees 1,021

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 301047

Full Company Profile

Financial Performance

In 2024, Sino Biological,Inc.'s revenue was 613.67 million, a decrease of -5.06% compared to the previous year's 646.39 million. Earnings were 121.93 million, a decrease of -53.13%.

Financial Statements